AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
28 Deli, Cheese, and Antipasti Suppliers Join ReposiTrak Traceability Network for Compliance with Wholesale Customers' Requirements
ByAinvest
Wednesday, Aug 27, 2025 7:04 am ET1min read
ReposiTrak has added 28 deli, cheese, and antipasti suppliers to its traceability network, meeting the growing demands of their retail customers. The companies will exchange intricate FDA-required data with the goal of meeting traceability requirements by 2025. ReposiTrak's solution requires no additional hardware and provides an error detection process to ensure data accuracy. The network is supported by a team of experts and provides a robust solution for retailers, suppliers, food manufacturers, and wholesalers to remain in compliance with regulatory requirements.
ReposiTrak, a leading traceability solution provider, has announced the addition of 28 new suppliers to its network, focusing on deli, cheese, and antipasti products. This move aims to address the growing demand for traceability in the retail sector, aligning with the Drug Supply Chain Security Act (DSCSA) compliance deadline of 2025.The new suppliers will exchange intricate FDA-required data through ReposiTrak's platform, which requires no additional hardware and offers an error detection process to ensure data accuracy. This solution is designed to help retailers, suppliers, food manufacturers, and wholesalers maintain compliance with regulatory requirements.
The expansion of ReposiTrak's network underscores the increasing importance of traceability in the food supply chain. As pharmaceutical distributors prepare for the DSCSA deadline, similar efforts are being made in the food industry to ensure the safety and integrity of products [1].
ReposiTrak's solution is supported by a team of experts who provide ongoing support and guidance to ensure compliance. This robust network is designed to help businesses navigate the complexities of data management and regulatory requirements, ultimately enhancing patient safety and building trust in the healthcare system [2].
References:
[1] https://www.tecsys.com/blog/crunch-time-3-dscsa-takeaways-from-hda-2025-traceability-seminar
[2] https://www.tecsys.com/blog/crunch-time-3-dscsa-takeaways-from-hda-2025-traceability-seminar
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet